Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and ...

If left untreated, there’s another condition ... This condition is called psoriatic arthritis. If you’re wondering how skin ...

Arthritis is one of the most common chronic conditions affecting millions of people worldwide. Yet, many fail to recognize ...

Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...

Concerning the untreated psoriatic lesions, five of the patients showed no change over four weeks, three experienced less scaling after application of emollient whereas in two patients a worsening ...

Interleukin-23 inhibitors may be able to reduce the risk of developing psoriatic arthritis among patients with psoriasis, ...

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...

A deeper understanding of the inflammatory processes driving psoriasis and psoriatic arthritis is translating into new research approaches that could potentially benefit patients. Psoriasis is a ...

IL-23, or IL-17 reduced serious infections, while tofacitinib increased infection risk, according to one study.